The second batch encourages the exposure of generic drug catalogues. What is a generic drug?

Generic drug refers to a generic drug that is basically the same as the brand name drug, mainly in dosage, safety, quality, indications and functional indications. Usually, after the drug protection period of some patents expires, some countries and drug manufacturers can use them to produce generic drugs.

Generic drugs can be seen together with the original drug. Generic drugs are actually derived from the original drug. For example, if a company invents a new drug, it will apply for patent protection, but there is also a time limit for patent protection, usually 20 years. Once this protection patent expires, other companies can manufacture and sell it with the approval of the drug supervision department. The production of generic drugs saves a lot of money, including drug research and development and marketing. Generic drugs are often cheaper, which is beneficial to some companies and saves costs.

Generic drugs are also strictly regulated by law. They must be exactly the same as the original medicine in effective components, including content and curative effect. After all, generic drugs are also approved and allowed by law. It is emphasized here that generic drugs are not fake and inferior products, nor can they be compared with other low-quality and inefficient imitations. Generic drugs also have certain benefits. For some patients who can't afford the expensive original drugs in the market, the advent of generic drugs can bring them certain benefits.

In China, we have always attached great importance to the development of generic drugs. After all, generic drugs are commonly used. To improve the quality of generic drugs, it is necessary to improve the technology and process, require higher standards for raw materials and packaging materials, and have stricter requirements for evaluation and approval. To promote these policies, we must support some new enterprises with innovative imitation ability. While dealing with imitation, we should also deal with the relationship between innovation. The competitiveness of pharmaceutical industry is still very strong. While encouraging generic drugs, we should also raise the requirements for the creation of new drugs, enhance international competitiveness and promote the strategy of sustainable development.